Journal of Chengde Medical University ›› 2026, Vol. 43 ›› Issue (1): 56-59.

Received:2025-05-23 Online:2026-02-10 Published:2026-02-12

¹²⁵I粒子植入术对中晚期胰腺癌患者治疗的研究进展

陈千慧¹, 王鑫², 徐海兰², 张晓彤¹, 刘镭¹, 张力^2,*

1.承德医学院临床技能教学中心,河北承德 067000;
2.承德医学院附属医院肿瘤科,河北承德 067000

通讯作者: ^*张力（1972—）,男,硕士,主任医师,研究方向：恶性肿瘤的综合治疗;E-mail：cd_zhangl@126.com
作者简介:陈千慧（1998—）,女,硕士,研究方向：恶性肿瘤的综合治疗。
基金资助:
国家自然科学基金项目（81703001）; 河北省自然科学基金项目（H2021406021; H2024406046）; 2024年承德市应用技术与开发暨可持续发展议程创新示范区专项科技计划项目（202404B009）; 河北省医学科学研究课题(20210247; 20221335）

Abstract

CLC Number:

R735.9

陈千慧, 王鑫, 徐海兰, 张晓彤, 刘镭, 张力. ¹²⁵I粒子植入术对中晚期胰腺癌患者治疗的研究进展[J]. 承德医学院学报, 2026, 43(1): 56-59.

Add to citation manager EndNote|Ris|BibTeX

URL: http://tougao.cdmc.edu.cn:8088/EN/

http://tougao.cdmc.edu.cn:8088/EN/Y2026/V43/I1/56

[1] Siegel RL, Giaquinto AN, Jemal A.Cancer statistics, 2024[J]. CA Cancer J Clin, 2024, 74(1): 12-49.
[2] Mcguigan A, Kelly P, Turkington RC, et al.Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes[J]. World J Gastroenterol, 2018, 24(43): 4846-4861.
[3] Simoni N, Rossi G, Cellini F, et al.Ablative Radiotherapy (ART) for Locally Advanced Pancreatic Cancer (LAPC): Toward a New Paradigm?[J]. Life (Basel), 2022, 12(4): 465.
[4] Liu L, Huang X, Shi F, et al.Combination therapy for pancreatic cancer: anti-PD-(L)1-based strategy[J]. J Exp Clin Cancer Res, 2022, 41(1): 56.
[5] Jia SN, Wen FX, Gong TT, et al.A review on the efficacy and safety of iodine-125 seed implantation in unresectable pancreatic cancers[J]. Int J Radiat Biol, 2020, 96(3): 383-389.
[6] Wijnen R, Pecoraro C, Carbone D, et al.Cyclin Dependent Kinase-1 (CDK-1) Inhibition as a Novel Therapeutic Strategy against Pancreatic Ductal Adenocarcinoma (PDAC)[J]. Cancers (Basel), 2021, 13(17): 4389.
[7] Zhou S, Zhu C, Chen SL, et al.(125)I Intracavitary Irradiation Combined with (125)I Seeds Implantation for Treatment of Locally Advanced Pancreatic Head Cancer: A Retrospective Analysis of 67 Cases[J]. Int J Gen Med, 2021, 14: 2645-2653.
[8] Wieners G, Schippers AC, Collettini F, et al.CT-guided high-dose-rate brachytherapy in the interdisciplinary treatment of patients with liver metastases of pancreatic cancer[J]. Hepatobiliary Pancreat Dis Int, 2015, 14(5): 530-538.
[9] Li Q, Tian Y, Yang D, et al.Permanent Iodine-125 Seed Implantation for the Treatment of Nonresectable Retroperitoneal Malignant Tumors[J]. Technol Cancer Res Treat, 2019, 18: 1533033819825845.
[10] Chen C, Wang W, Wang W, et al.Locally advanced pancreatic carcinoma with jaundice: the benefit of a sequential treatment with stenting followed by CT-guided (125)I seeds implantation[J]. Eur Radiol, 2021, 31(9): 6500-6510.
[11] Schwarz K, Dobiasch S, Nguyen L, et al.Modification of radiosensitivity by Curcumin in human pancreatic cancer cell lines[J]. Sci Rep, 2020, 10(1): 3815.
[12] Li CG, Zhou ZP, Jia YZ, et al.Radioactive (125)I seed implantation for locally advanced pancreatic cancer: A retrospective analysis of 50 cases[J]. World J Clin Cases, 2020, 8(17): 3743-3750.
[13] Mai Q, Mo Z, He J, et al.Feasibility and clinical value of computed tomography-guided(125)I brachytherapy for pain palliation in patients with retroperitoneal lymph node metastases[J]. J Cancer Res Ther, 2020, 16(2): 372-378.
[14] Liu B, Zhou T, Geng J, et al.Percutaneous computed tomography-guided iodine-125 seeds implantation for unresectable pancreatic cancer[J]. Indian J Cancer, 2015, 52(Suppl 2): e69-74.
[15] Zhongmin W, Yu L, Fenju L, et al.Clinical efficacy of CT-guided iodine-125 seed implantation therapy in patients with advanced pancreatic cancer[J]. Eur Radiol, 2010, 20(7): 1786-1791.
[16] Wang DM, Liu YH, Yu SP, et al.Intraoperative ¹²⁵I brachytherapy combined with chemotherapy for pancreatic cancer[J]. Zhonghua Zhong Liu Za Zhi, 2004, 26(7): 433-436.
[17] Huang S, Cao Y, Wang R, et al.Feasibility of 125I brachytherapy combined with arterial infusion chemotherapy in patients with advanced pancreatic cancer[J]. Medicine (Baltimore), 2023, 102(44): e35033.
[18] Ji L, Zhang W, Hao S, et al.Percutaneous transhepatic cholangial drainage combined with intra-tumoral iodine-125 seeds implantation and chemotherapy for locally progressive pancreatic head cancer with obstructive jaundice[J]. J Contemp Brachytherapy, 2022, 14(5): 462-469.
[19] Magill ST, Schwartz TH, Theodosopoulos PV, et al.Brachytherapy for meningiomas[J]. Handb Clin Neurol, 2020, 170: 303-307.
[20] Ying XH, Zhang DK, Chen L, et al.Differential population screening and efficacy analysis of (125)I implantation after radiofrequency ablation of primary liver cancer[J]. Zhonghua Yi Xue Za Zhi, 2020, 100(17): 1310-1314.
[21] Kobayashi K, Murakami N, Takahashi K, et al.Tensor Regression-based Model to Investigate Heterogeneous Spatial Radiosensitivity After I-125 Seed Implantation for Prostate Cancer[J]. In Vivo, 2021, 35(1): 489-497.
[22] Lin C, Yang Z, Liu Q.Effect of I-125 Seed Implantation on Lung Cancer and Its Environmental Impact[J]. Health Phys, 2023, 125(4): 273-280.
[23] Lv WF, Lu D, Xiao JK, et al.The side effects and complications of percutaneous iodine-125 seeds implantation under CT-guide for patients with advanced pancreatic cancer[J]. Medicine (Baltimore), 2017, 96(52): e9535.
[24] Liu K, Ji B, Zhang W, et al.Comparison of iodine-125 seed implantation and pancreaticoduodenectomy in the treatment of pancreatic cancer[J]. Int J Med Sci, 2014, 11(9): 893-896.
[25] Chen JB, Li JL, He LH, et al.Radical treatment of stage IV pancreatic cancer by the combination of cryosurgery and iodine-125 seed implantation[J]. World J Gastroenterol, 2012, 18(47): 7056-7062.
[26] Wang Y, Kang P, He W, et al.MR-guided ¹²⁵I seed implantation treatment for maxillofacial malignant tumor[J]. J Appl Clin Med Phys, 2021, 22(1): 92-99.
[27] Wang B, Qiu B, Wu L, et al.Efficacy and safety of 3D printing coplanar template-assisted iodine-125 seed implantation as palliative treatment for inoperable pancreatic cancer[J]. J Contemp Brachytherapy, 2022, 14(2): 140-147.
[28] Laface C, Laforgia M, Molinari P, et al.Intra-Arterial Infusion Chemotherapy in Advanced Pancreatic Cancer: A Comprehensive Review[J]. Cancers(Basel), 2022, 14(2): 450.
[29] Sawada M, Kasuga A, Mie T, et al.Modified FOLFIRINOX as a second-line therapy following gemcitabine plus nab-paclitaxel therapy in metastatic pancreatic cancer[J]. BMC Cancer, 2020, 20(1): 449.
[30] Galluzzi L, Vacchelli E, Bravo-sanpedro JM, et al. Classification of current anticancer immunotherapies[J]. Oncotarget, 2014, 5(24): 12472-12508.
[31] Bear AS, Vonderheide RH, O'hara MH. Challenges and Opportunities for Pancreatic Cancer Immunotherapy[J]. Cancer Cell, 2020, 38(6): 788-802.
[32] Hu HF, Ye Z, Qin Y, et al.Mutations in key driver genes of pancreatic cancer: molecularly targeted therapies and other clinical implications[J]. Acta Pharmacol Sin, 2021, 42(11): 1725-1741.
[33] Zhou L, Yang H, Xie L, et al.Comparison of Image-Guided Iodine-125 Seed Interstitial Brachytherapy and Local Chemotherapy Perfusion in Treatment of Advanced Pancreatic Cancer[J]. J Invest Surg, 2022, 35(1): 1-6.

¹²⁵I粒子植入术对中晚期胰腺癌患者治疗的研究进展

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 3

Recommended Articles

Metrics

Comments

[1]	ZHANG Wen-jie, DAI Jun. Relationship between PRDM14, IGFBP2 Levels and Microvascular Density in Patients with Pancreatic Cancer before and after Surgery [J]. Journal of Chengde Medical University, 2024, 41(5): 377-381.
[2]	SHI Yu-cheng, ZHANG Xu-ying. Clinical Significance of Serum CA19-9, MUC5AC, and Exo-EphA2 in Pancreatic Cancer and Mass Pancreatitis [J]. Journal of Chengde Medical University, 2024, 41(3): 203-206.
[3]	. [J]. Journal of Chengde Medical University, 2023, 40(6): 513-515.

125I粒子植入术对中晚期胰腺癌患者治疗的研究进展

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 3

Recommended Articles

Metrics

Comments

¹²⁵I粒子植入术对中晚期胰腺癌患者治疗的研究进展